AIPPI 2017: Eli Lilly counsel discusses ‘convoluted’ Amgen v Sanofi ruling

17-10-2017

AIPPI 2017: Eli Lilly counsel discusses ‘convoluted’ Amgen v Sanofi ruling

jetcityimage / iStockphoto.com

A patent counsel at Eli Lilly discussed a recent dispute pitting Amgen against Sanofi and Regeneron, saying an appeals court ruling was convoluted.


Innovation, Eli Lilly, litigation, permanent injunction, injunction, Amgen, Regeneron, Sanofi, innovator, patent, patent infringement,

LSIPR